Trial intelligence / Profile preview

Combination Chemotherapies in Advanced Non-Small Cell Lung Cancer

NCT00003589Phase 3Completed

Sponsor
European Organisation for Research and Treatment of Cancer
Start
Aug 1998
Primary completion
Jul 2000
Modality
Small Molecules
Countries
12
01

Overview

A Phase 3 trial of paclitaxel, cisplatin, gemcitabine in non-small cell lung cancer (NSCLC), sponsored by European Organisation for Research and Treatment of Cancer. Started Aug 1998; status: completed.

02

Drugs

paclitaxelcisplatingemcitabine
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT00003589.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003589.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call